ReP USP - Resultado da busca

Artigo de periodico
Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia (2020)
Weinhäuser, Isabel ; Martins, Diego Antonio Pereira ; Ortiz, César; Silveira, Douglas Rafaele Almeida ; Simões, Luíse Araújo de Albuquerque; Bianco, Thiago Mantello ; Araujo, Cleide L.; Melo, Raul A. M.; Bittencourt, Rosane I.; Pagnano, Katia; Rego, Eduardo Magalhães
Source: Cancers. Unidades: FM, FMRP
Subjects: PROLIFERAÇÃO CELULAR, TIROXINA, ARSÊNIO, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINHÄUSER, Isabel et al. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia. Cancers, v. 12, n. 11, p. 1-16, 2020Tradução . . Disponível em: https://doi.org/10.3390/cancers12113134. Acesso em: 21 jun. 2024.
APA
Weinhäuser, I., Martins, D. A. P., Ortiz, C., Silveira, D. R. A., Simões, L. A. de A., Bianco, T. M., et al. (2020). Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia. Cancers, 12( 11), 1-16. doi:10.3390/cancers12113134
NLM
Weinhäuser I, Martins DAP, Ortiz C, Silveira DRA, Simões LA de A, Bianco TM, Araujo CL, Melo RAM, Bittencourt RI, Pagnano K, Rego EM. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia [Internet]. Cancers. 2020 ; 12( 11): 1-16.[citado 2024 jun. 21 ] Available from: https://doi.org/10.3390/cancers12113134
Vancouver
Weinhäuser I, Martins DAP, Ortiz C, Silveira DRA, Simões LA de A, Bianco TM, Araujo CL, Melo RAM, Bittencourt RI, Pagnano K, Rego EM. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia [Internet]. Cancers. 2020 ; 12( 11): 1-16.[citado 2024 jun. 21 ] Available from: https://doi.org/10.3390/cancers12113134
Artigo de periodico
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020)
Thomé, Carolina Hassibe ; Ferreira, Germano Aguiar ; Martins, Diego Antonio Pereira ; Santos, Guilherme Augusto dos; Ortiz, César Alexander; Souza, Lucas Eduardo Botelho de ; Sobral, Lays Martins; Silva, Cleide Lúcia Araújo; Scheucher, Priscila Santos ; Gil, Cristiane Damas; Leopoldino, Andréia Machado ; Silveira, Douglas Rafaele Almeida ; Silva, Juan Luiz Coelho da ; Traina, Fabiola ; Koury, Luisa C.; Melo, Raul A. M.; Bittencourt, Rosane; Pagnano, Katia; Pasquini, Ricardo; Nunes, Elenaide C.; Fagundes, Evandro M.; Gloria, Ana Beatriz F.; kerbauy, Fábio Rodrigues; Chauffaille, Maria de Lourdes; Keating, Armand; Tallman, Martin S.; Ribeiro, Raul C.; Dillon, Richard; Ganser, Arnold; Löwenberg, Bob; Valk, Peter; Lo-Coco, Francesco; Sanz, Miguel A.; Berliner, Nancy; Faça, Vitor Marcel ; Rego, Eduardo Magalhaes
Source: Scientific Reports. Unidades: FMRP, FCFRP, FM
Subjects: PROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, QUIMIOTERAPIA, ANTINEOPLÁSICOS, MEDULA ÓSSEA, DIFERENCIAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, LEUCEMIA, FARMACOTERAPIA, ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THOMÉ, Carolina Hassibe et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-66223-2. Acesso em: 21 jun. 2024.
APA
Thomé, C. H., Ferreira, G. A., Martins, D. A. P., Santos, G. A. dos, Ortiz, C. A., Souza, L. E. B. de, et al. (2020). NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, 10( 1). doi:10.1038/s41598-020-66223-2
NLM
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 jun. 21 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Vancouver
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 jun. 21 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Artigo de periodico
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia (2017)
Lucena-Araujo, Antonio R.; Pereira-Martins, Diego A.; Koury, Luisa C.; Franca-Neto, Pedro L.; Coelho-Silva, Juan L.; Wagatsuma, Virginia M. de Deus; Melo, Raul A. M.; Bittencourt, Rosane; Pagano, Katia; Rego, Eduardo Magalhães
Source: Blood Advances. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCENA-ARAUJO, Antonio R. et al. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. Blood Advances, v. 1, n. 21, p. 1807-1814, 2017Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017005926. Acesso em: 21 jun. 2024.
APA
Lucena-Araujo, A. R., Pereira-Martins, D. A., Koury, L. C., Franca-Neto, P. L., Coelho-Silva, J. L., Wagatsuma, V. M. de D., et al. (2017). Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. Blood Advances, 1( 21), 1807-1814. doi:10.1182/bloodadvances.2017005926
NLM
Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, Wagatsuma VM de D, Melo RAM, Bittencourt R, Pagano K, Rego EM. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia [Internet]. Blood Advances. 2017 ; 1( 21): 1807-1814.[citado 2024 jun. 21 ] Available from: https://doi.org/10.1182/bloodadvances.2017005926
Vancouver
Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, Wagatsuma VM de D, Melo RAM, Bittencourt R, Pagano K, Rego EM. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia [Internet]. Blood Advances. 2017 ; 1( 21): 1807-1814.[citado 2024 jun. 21 ] Available from: https://doi.org/10.1182/bloodadvances.2017005926

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration